长春高新(000661.SZ)子公司三价流感病毒裂解疫苗(BK-01佐剂)临床试验申请获批准

智通财经
Oct 13

智通财经APP讯,长春高新(000661.SZ)公告,公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》,同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10